Maffulli Nicola, Walley Gayle, Sayana Murali K, Longo Umile Giuseppe, Denaro Vincenzo
Department of Trauma and Orthopaedic Surgery, University Hospital of North Staffordshire, Keele University School of Medicine, Stoke on Trent, UK.
Disabil Rehabil. 2008;30(20-22):1677-84. doi: 10.1080/09638280701786427.
To evaluate the effects of eccentric strengthening exercises (ESE) in athletic patients with Achilles tendinopathy.
Forty-five athletic patients (29 men, average age 26 years +/- 12.8, range 18 - 42; 16 women, average age 28 years +/- 13.1, range 20 - 46; average height: 173 +/- 16.8, range 158 - 191; average weight 70.8 kg +/- 15.3, range 51.4 - 100.5) with a clinical diagnosis of unilateral tendinopathy of the main body of the Achilles tendon completed the VISA-A questionnaire at first attendance and at their subsequent visits. The patients underwent a graded progressive eccentric calf strengthening exercises programme for 12 weeks.
The mean pre-management VISA-A scores of 36 (SD 23.8; 95% CI: 29 - 46) improved to 52 (SD 27.5; 95% CI: 41.3 - 59.8) at the latest follow up (p = 0.001). Twenty seven of the 45 patients responded to the eccentric exercises. Of the 18 patients who did not improve with eccentric exercises, 5 (mean age: 33 years) improved with two peritendinous aprotinin and local anaesthetic injections. 10 of the 18 patients (9 men, mean age 35 years; 1 woman aged 40 years) who did not improve with eccentric exercises and aprotinin injections proceeded to have surgery. The remaining three patients (3 women, mean age 59.6 years) of the 18 non-responders to eccentric exercises and aprotinin injections declined surgical intervention.
ESE in athletic patients provide comparable clinical outcome compared to our previous results in non-athletic patients. ESE are a viable option for the management of AT in athletes, but, in our hands, only around 60% of our athletic patients benefited from an intensive, heavy load eccentric heel drop exercise regimen alone. If ESE fail to improve the symptoms, aprotinin and local anaesthetic injections should be considered. Surgery is indicated in recalcitrant cases after 3 to 6 months of non operative management.
评估离心强化训练(ESE)对患有跟腱病的运动员患者的疗效。
45例临床诊断为单侧跟腱主体腱病的运动员患者(29名男性,平均年龄26岁±12.8岁,范围18 - 42岁;16名女性,平均年龄28岁±13.1岁,范围20 - 46岁;平均身高:173±16.8,范围158 - 191;平均体重70.8kg±15.3,范围51.4 - 100.5)在首次就诊及随后的随访中完成了VISA - A问卷。患者接受了为期12周的分级渐进式离心小腿强化训练计划。
在最新随访时,管理前VISA - A平均得分36(标准差23.8;95%置信区间:29 - 46)提高到了52(标准差27.5;95%置信区间:41.3 - 59.8)(p = 0.001)。45例患者中有27例对离心训练有反应。在18例未因离心训练改善的患者中,5例(平均年龄:33岁)通过两次腱周抑肽酶和局部麻醉剂注射得到改善。18例未因离心训练和抑肽酶注射而改善的患者中,10例(9名男性,平均年龄35岁;1名40岁女性)接受了手术。18例对离心训练和抑肽酶注射无反应的患者中,其余3例(3名女性,平均年龄59.6岁)拒绝手术干预。
与我们之前对非运动员患者的研究结果相比,运动员患者进行离心强化训练后的临床结果相当。离心强化训练是运动员跟腱病管理的一个可行选择,但在我们的研究中,仅约60%的运动员患者仅通过强化、重负荷离心足跟下降训练方案获益。如果离心强化训练未能改善症状,应考虑使用抑肽酶和局部麻醉剂注射。在非手术治疗3至6个月后仍顽固不愈的病例中,需进行手术治疗。